Pankaj Gupta

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

H. Bachelez, P.C.M. van de Kerkhof, Robert Strohal et al. · The Lancet · 2015 · 388 citations · Full text

Autoimmune Disease, Clinical Trials, Inflammatory Marker +7

VEGF Prevents Apoptosis of Human Microvascular Endothelial Cells via Opposing Effects on MAPK/ERK and SAPK/JNK Signaling

Kalpna Gupta, Smita Kshirsagar, Wei Li et al. · Experimental Cell Research · 1999 · 380 citations

Vegf Prevents Apoptosis, Angiogenesis, Opposing Effects +12

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study

Kim Papp, Alan Menter, Bruce Strober et al. · British Journal of Dermatology · 2012 · 328 citations

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

Kim Papp, Alan Menter, Mai Abe et al. · British Journal of Dermatology · 2015 · 310 citations · Full text

Efficacy and Safety of CE-224,535, an Antagonist of P2X₇Receptor, in Treatment of Patients with Rheumatoid Arthritis Inadequately Controlled by Methotrexate

Thomas Stock, Bradley J. Bloom, Nathan Wei et al. · The Journal of Rheumatology · 2012 · 232 citations · Full text